2022
DOI: 10.1016/j.gendis.2021.08.010
|View full text |Cite
|
Sign up to set email alerts
|

The potential regulatory role of BMP9 in inflammatory responses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 129 publications
(148 reference statements)
0
2
0
Order By: Relevance
“…[ 46 ] Different from other BMPs, BMP9 is distinguished because of its potent activity, most likely attributable to the fact that it cannot be inhibited by extracellular antagonists, such as Noggin and BMP3. [ 47 ] Notably, BMP3 can suppress osteogenic differentiation and negatively regulates bone density by modulating TGF‐β receptor availability to other ligands. [ 48 ] According to bioinformatic analyses of global transcriptomic changes by RNA‐seq of human gingival tissues, BMP2, BMP7, and BMP receptors (like BMPR1A and BMPR2) are significantly decreased for the diseased patients relative to the healthy ones, while BMP3 is significantly increased (Figure S12, Supporting Information).…”
Section: Resultsmentioning
confidence: 99%
“…[ 46 ] Different from other BMPs, BMP9 is distinguished because of its potent activity, most likely attributable to the fact that it cannot be inhibited by extracellular antagonists, such as Noggin and BMP3. [ 47 ] Notably, BMP3 can suppress osteogenic differentiation and negatively regulates bone density by modulating TGF‐β receptor availability to other ligands. [ 48 ] According to bioinformatic analyses of global transcriptomic changes by RNA‐seq of human gingival tissues, BMP2, BMP7, and BMP receptors (like BMPR1A and BMPR2) are significantly decreased for the diseased patients relative to the healthy ones, while BMP3 is significantly increased (Figure S12, Supporting Information).…”
Section: Resultsmentioning
confidence: 99%
“…Even though the precise distribution varies slightly between species ( 53 ), in general, bone morphogenetic protein 9 (BMP9) is considered to be mainly expressed in the liver of adult individuals as a circulating factor produced by hepatic stellate cells ( 54 ). In managing liver sinusoidal endothelial cells fenestration and guarding against perivascular hepatic fibrosis, it is a crucial paracrine regulator of liver homeostasis ( 55 , 56 ).…”
Section: Hepatokines: From Liver To Bonementioning
confidence: 99%